All articles about Application Area
Application Area
Which countries is CAR T-cell therapy available in?
The geographical and socioeconomic distribution of CAR T-cell therapy is still leaving space for improvement. Read the following article to find out why and how Single Use Support will help!
Michael Eder
November 25, 2021
Application Area
Success rate of a CAR T-cell therapy
Success rate of a CAR T-cell therapy | reliable and sterile logistics process | Single Use Support's scalable and agile systems based on single-use compounds will help - read more!
Michael Eder
November 25, 2021
Application Area
FDA approved CAR T-cell therapies
CAR T-cell therapy represents a new and innovative approach to cancer immunotherapy. To make CAR T-cell therapy work better with lowered costs, it is essential to arrive at scalable single-use technology solutions - read more how SUSupport offers leading solutions!
Michael Eder
November 25, 2021
Application Area
Single Use Support investing 20 Mio EUR in end-to-end solutions for cell & gene therapies
Single Use Support invests 20 Mio. EUR in development and research of Biopharma novel process solutions in cell & gene therapies. The Austrian company’s next upcoming innovation will be the launch of its own single-use bags.
Michael Eder
November 17, 2021
Application Area
Single Use Support providing solutions for gene therapies
Biopharma solution provider Single Use Support announces an order from Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO).
Michael Eder
September 8, 2021
Application Area
Loss of drug substance - the challenges and chances of product loss
In recent years, if not decades, gene therapies have proven to be key drivers of growth in the pharmaceutical industry. Learn more how SUSupport takes on the chances in loss of drug substances.
Claus Exenberger
August 24, 2021
Application Area
CAR NK therapy - natural killer cell therapy - what is that?
CAR-NK therapies are a new approach to combat cancer cells.
This article sheds light on its advantages and logistical challenges to avoid loss of these highly valuable drug substances and scalability.
Michael Eder
August 19, 2021
Application Area
Standardizing CAR-T therapy - Getting it scaled up!
The fields of gene and cellular therapy such as CAR-T and CGT therapy, are characterized by continuous development alongside rapid growth. Read everything about the scaling process of this industry!
Michael Eder
July 29, 2021
Application Area
Evaluating freeze-thaw processes in antibody production
In a field as sensitive as monoclonal antibody development and production, controlled processes and procedures have always played a vital role and will continue to do so. Learn more why Single-use technologies are highly flexible, scalable and on another quality level.
Michael Eder
December 18, 2020
Application Area
eBook: Advancing Cell and Gene Therapies
Putting cell & gene therapies into practice requires complex logistics. Our new eBook will show you solutions to simplify complex process logistics.
Michael Eder
December 18, 2020
Application Area
Seed train intensification - the next big step in biopharma?
Labs and manufacturers feel the pressure to deliver at a constantly accelerating pace while remaining flexible. In this article, you will learn how Single Use Support can bring you to the next level!
Michael Eder
July 29, 2020
Application Area
CAR T-cell therapy - the process and side effects
Read more about CAR-T cell therapy, its history and hurdles. Learn also how Single Use Support can support this novel therapy with great potential!
Michael Eder
July 23, 2020
Discover more topics
Articles by Application Area:
Articles by Solution: